Your browser doesn't support javascript.
loading
Improvement of current immunotherapies with engineered oncolytic viruses that target cancer stem cells.
Soroush, Alborz; Shahhosseini, Reza; Ghavamikia, Nima; Hjazi, Ahmed; Roudaki, Shahrzad; KhalatbariLimaki, Mahdi; Mirbolouk, Mahtab; Pakmehr, SeyedAbbas; Karimi, Parvin.
Affiliation
  • Soroush A; Ramsay Pharmacy Group, Melbourne, Australia.
  • Shahhosseini R; Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey.
  • Ghavamikia N; Cardiovascular Research Institute, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Hjazi A; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin AbdulAziz University, Al-Kharj, Saudi Arabia.
  • Roudaki S; School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  • KhalatbariLimaki M; School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
  • Mirbolouk M; School of Pharmacy, Cyprus International University, Nicosia, North Cyprus.
  • Pakmehr S; School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Karimi P; Fars Population-Based Cancer Registry, Shiraz University of Medical Sciences, Shiraz, Iran.
Cell Biochem Funct ; 42(4): e4055, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38856033

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Oncolytic Viruses / Oncolytic Virotherapy / Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Cell Biochem Funct Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplastic Stem Cells / Oncolytic Viruses / Oncolytic Virotherapy / Immunotherapy / Neoplasms Limits: Animals / Humans Language: En Journal: Cell Biochem Funct Year: 2024 Document type: Article Affiliation country: Country of publication: